Tech Company M&A Transactions
Tanox Acquisition
Tanox, based in Houston, was acquired by Genentech. Genentech said the transaction price was $919 million.
Transaction Overview
Company Name
Acquired By
Announced On
11/9/2006
Transaction Type
M&A
Amount
$919,000,000
M&A Terms
The acquisition is subject to approval of
Tanox's shareholders and customary closing conditions, including clearance
under the Hart-Scott-Rodino Act. The transaction is expected to be
completed by the end of the first quarter of 2007. Funds will be provided
from Genentech's cash on hand at the time of closing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
10555 Stella Link
Houston, TX 77025
USA
Houston, TX 77025
USA
Phone
Website
Email Address
Not Recorded
Overview
Tanox is a biotechnology company specializing in the development ofmonoclonal antibodies. The company develops innovative biotherapeutics forthe treatment of immune-mediated diseases, inflammation, infectious diseaseand cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Nancy Chang
Browse more venture capital transactions:
Prev: 11/8/2006: Solstice Neurosciences venture capital transaction
Next: 11/9/2006: BlackArrow venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs